Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelines
- 15 April 2019
- journal article
- research article
- Published by Taylor & Francis in International Journal of Psychiatry in Clinical Practice
- Vol. 23 (3) , 178-188
Abstract
Objectives: Borderline personality disorder (BPD) is a life-threatening mental disorder. Guideline recommendations for pharmacological treatment of patients with BPD vary widely. The objective of the present study was to investigate pharmacotherapy of BPD patients in a routine clinical care setting. Methods: Data on the pharmacological treatment of 110 patients (90% female) with BPD (F- 60.3), treated in an inpatient psychiatric-psychosomatic clinic in Austria were assessed. Results: Results show that clinicians frequently prescribe psychotropic medications to patients with BPD, in many cases multiple medications. The most commonly prescribed substance groups were antipsychotics, mood stabilisers and antidepressants. The most commonly prescribed individual drugs were Quetiapine, Lamotrigine and Setraline. There was no significant difference in the different types or overall number of medications prescribed to BPD patients with vs. without comorbid diagnoses. Pharmacotherapy was not related to comorbidity. Conclusions: The present study shows that in routine clinical care settings psychotropic medications are frequently prescribed to patients with BPD, very often resulting in polypharmacy. A positive association between the number of medications and the effectiveness of the inpatient treatment program, as well as the absence of a relationship between number of medications and comorbidity contradicts the often suggested iatrogenic effect of polypharmacy.Keywords
This publication has 57 references indexed in Scilit:
- Ten-Year Course of Borderline Personality DisorderArchives of General Psychiatry, 2011
- Differential Effectiveness of Antipsychotics in Borderline Personality DisorderJournal of Clinical Psychopharmacology, 2011
- Comorbidity and Associated Severity of Borderline Personality Disorder and Physical Health Conditions in a Nationally Representative SamplePsychosomatic Medicine, 2010
- Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trialsThe British Journal of Psychiatry, 2010
- The course of eating disorders in patients with borderline personality disorder: A 10‐year follow‐up studyInternational Journal of Eating Disorders, 2009
- Epidemiology of Personality DisordersPsychiatric Clinics of North America, 2008
- Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Borderline Personality DisorderThe Journal of Clinical Psychiatry, 2008
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Personality DisordersThe World Journal of Biological Psychiatry, 2007
- Personality disorders and medical comorbidityCurrent Opinion in Psychiatry, 2006
- Der deutsche SF-36 Health Survey Übersetzung und psychometrische Testung eines krankheitsübergreifenden Instruments zur Erfassung der gesundheitsbezogenen LebensqualitätJournal of Public Health, 1995